Literature DB >> 16441367

Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.

Yuji Hodo, Kirokazu Tsuji, Eishiro Mizukoshi, Tatsuya Yamashita, Akito Sakai, Yasunari Nakamoto, Masao Honda, Shuichi Kaneko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441367     DOI: 10.1111/j.1432-2277.2005.00242.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  5 in total

1.  Pure red cell aplasia caused by ribavirin and interferon treatment.

Authors:  Andrew J Skabelund; Timothy R Hauser; Kevin J Goist
Journal:  Clin J Gastroenterol       Date:  2011-07-30

2.  Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige; Etsuko Hashimoto; Makiko Taniai; Akiko Omori; Yoshihito Kotera; Hiroto Egawa; Masakazu Yamamoto; Keiko Shiratori
Journal:  Clin J Gastroenterol       Date:  2015-05-12

3.  A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.

Authors:  James R Burton; Jacqueline G O'Leary; Elizabeth C Verna; Varun Saxena; Jennifer L Dodge; Richard T Stravitz; Joshua Levitsky; James F Trotter; Gregory T Everson; Robert S Brown; Norah A Terrault
Journal:  J Hepatol       Date:  2014-05-05       Impact factor: 25.083

Review 4.  Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Authors:  Ting-Bo Liang; Dong-Lin Li; Jun Yu; Xue-Li Bai; Liang Liang; Shi-Guo Xu; Wei-Lin Wang; Yan Shen; Min Zhang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

5.  Hemolytic Anemia after Acute Hepatitis B Virus Infection: A Case Report and Systematic Review.

Authors:  Takahiro Suzuki; Takeshi Okamoto; Fujimi Kawai; Shuhei Okuyama; Katsuyuki Fukuda
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.